Design of a Novel Fab‐Like Antibody Fragment with Enhanced Stability and Affinity for Clinical use (Small Methods 2/2022)
Chunyu Wang(Shanghai Medical College of Fudan University), Tianlei Ying(Shanghai Medical College of Fudan University), Xingtao Zhou(Nanchang University), Zhenlin Yang(Fudan University), Jiaxu Hong(Eye & ENT Hospital of Fudan University), Xujiao Zhou(Fudan University), Dimiter S. Dimitrov(University of Pittsburgh), Yu Kong(Fudan University), Yuhan Yang(Sichuan University), Yanling Wu(Shanghai Medical College of Fudan University), Binfan Chen(Shanghai Medical College of Fudan University), Huifang Wu(Shanghai Medical College of Fudan University), Bin‐Zhi Qian(Fudan University)
Cited by 0
Related Papers
Fusion mechanism of 2019-nCoV and fusion inhibitors targeting HR1 domain in spike protein
|Cellular and Molecular Immunology|2020|759
Identification of Human Single-Domain Antibodies against SARS-CoV-2
|Cell Host & Microbe|2020|283
Identification of GPC2 as an Oncoprotein and Candidate Immunotherapeutic Target in High-Risk Neuroblastoma
|Cancer Cell|2017|229
RBD-Fc-based COVID-19 vaccine candidate induces highly potent SARS-CoV-2 neutralizing antibody response
|Signal Transduction and Targeted Therapy|2020|213
Targeting herpes simplex virus with CRISPR–Cas9 cures herpetic stromal keratitis in mice
|Nature Biotechnology|2021|186